Axtria White Paper
White Paper

Is It Time To Adjust The Pharma PDE Sales Force Optimization Model?

The question this white paper addresses is straightforward – will COVID-19 call for restructuring the long-standing pharma PDE (primary detail equivalent) salesforce optimization model? The PDE model has been a go-to metric for sales response modeling, salesforce optimization, and sales operations analyses for 20+ years. However, with the implications of COVID-19 on the global healthcare market, pharma companies are rethinking their commercial strategies, as noted in this white paper series.

This white paper provides a detailed review and assessment of only using PDEs in the post-COVID-19 sales response modeling, and the adjustments needed now in the pharma PDE salesforce optimization model.

Dr. George A. Chressanthis is currently Principal Scientist at Axtria. He brings a unique combination of professional experiences into the analysis of strategic and operational issues affecting the biopharmaceutical industry.

Dr. Kedar Naphade is a Senior Principal at Axtria. He has over a dozen years of experience helping organizations create and institute innovative analytical decision making processes.

Complete the brief form to download the white paper.

Contact us at with any questions.

Get Your Copy!

Suggested Blogs

Let Us Show You What Axtria’s 

Solutions Can Do For You